Literature DB >> 12885134

Comparison of the efficacy and cardiorespiratory effects of medetomidine-based anesthetic protocols in ring-tailed lemurs (Lemur catta).

Cathy V Williams1, Kelly M Glenn, Jay F Levine, William A Horne.   

Abstract

The relative efficacies and cardiorespiratory effects of three injectable anesthetic combinations containing medetomidine were evaluated in ring-tailed lemurs (Lemur catta). In addition, the direct effects of medetomidine on heart rate and blood pressure were evaluated in lemurs anesthetized with isoflurane. For injectable anesthesia, captive adult ring-tailed lemurs were anesthetized with medetomidine and ketamine (0.04-0.06 mg/kg, i.m. and 3 mg/kg, i.m., respectively), medetomidine, butorphanol, and ketamine (0.04 mg/kg, i.m., 0.4 mg/kg, i.m., and 3 mg/kg, i.m., respectively), or medetomidine, butorphanol, and midazolam (0.04 mg/kg, i.m., 0.4 mg/kg, i.m., and 0.3 mg/kg, i.m., respectively). For inhalation anesthesia, lemurs were mask-induced and maintained with isoflurane for 30 min before receiving medetomidine (0.04 mg/kg, i.m.). Sedation produced by medetomidine-ketamine was unpredictable and of short duration. Both medetomidine-butorphanol-ketamine (MBK) and medetomidine-butorphanol-midazolam (MBMz) provided adequate anesthesia for routine physical exams; however, the effects of MBMz lasted longer than those of MBK. Heart rates and respiratory rates were within clinically normal ranges for all groups, and lemurs remained normotensive throughout the study. Common side effects such as hypertension and bradycardia associated with the use of alpha2-adrenergic receptor agonist combinations in other species were not observed. Likewise, medetomidine administration had no effect on HR in lemurs receiving isoflurane. Lemurs in all groups were well ventilated and remained well oxygenated throughout the procedures, though arterial partial pressure of O2 was lowest in the MBMz group. All three injectable medetomidine combinations were effective in ring-tailed lemurs but only MBK and MBMz provided adequate depth and duration of anesthesia for use as sole regimes. For many clinical procedures in lemurs, MBMz offers advantages over MBK because of its longer duration of action and its rapid and more complete reversibility with specific antagonists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885134     DOI: 10.1638/1042-7260(2003)034[0163:COTEAC]2.0.CO;2

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  5 in total

1.  Comparison of the effects of ketamine, ketamine-medetomidine, and ketamine-midazolam on physiologic parameters and anesthesia-induced stress in rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques.

Authors:  Vanessa K Lee; Kendall S Flynt; Lauren M Haag; Douglas K Taylor
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-01       Impact factor: 1.232

2.  Minimum Alveolar Concentration and Cardiopulmonary Effects of Isoflurane in Ring-tailed Lemurs (Lemur catta).

Authors:  Sathya K Chinnadurai; Julie A Balko; Cathy V Williams
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-07-01       Impact factor: 1.232

3.  A Comparison of the Efficacy and Cardiopulmonary Effects of 3 Different Sedation Protocols in Otolemur garnettii.

Authors:  Kelsey R Finnie; Carissa P Jones; William D Dupont; Kenneth J Salleng; Katherine A Shuster
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-07-21       Impact factor: 1.232

4.  Combination of intramuscular alfaxalone, butorphanol, and midazolam as a novel immobilization protocol in 3 ring-tailed lemurs (Lemur catta).

Authors:  Kyratsoula Pentsou; Vilhelmiina Huuskonen
Journal:  Ir Vet J       Date:  2020-06-16       Impact factor: 2.146

5.  Anesthetic effect of a combination of medetomidine-midazolam-butorphanol in cynomolgus monkeys (Macaca fascicularis).

Authors:  Takehiro Ochi; Ippei Nishiura; Mitsuyoshi Tatsumi; Yoshimi Hirano; Kouichi Yahagi; Yasuhiro Sakurai; Kanako Matsuyama-Fujiwara; Yuji Sudo; Noriko Nishina; Hironari Koyama
Journal:  J Vet Med Sci       Date:  2014-03-03       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.